APA (7th ed.) Citation

Y, X., R, K., JF, Z., Y, B., O, O., S, S., . . . H, Z. (2026). Shifting a paradigm: Highlights of model informed drug development in dosage selection and optimization for oncology products. The oncologist, 31(6), . https://doi.org/10.1093/oncolo/oyag154

Chicago Style (17th ed.) Citation

Y, Xiong, et al. "Shifting a Paradigm: Highlights of Model Informed Drug Development in Dosage Selection and Optimization for Oncology Products." The Oncologist 31, no. 6 (2026). https://doi.org/10.1093/oncolo/oyag154.

MLA (9th ed.) Citation

Y, Xiong, et al. "Shifting a Paradigm: Highlights of Model Informed Drug Development in Dosage Selection and Optimization for Oncology Products." The Oncologist, vol. 31, no. 6, 2026, https://doi.org/10.1093/oncolo/oyag154.